Literature DB >> 6358418

Biologicals: new horizons in pharmaceutical development.

R K Oldham.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6358418

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN： 0732-6580


× No keyword cloud information.
  2 in total

1.  Phase I trial of ImuVert (natural membrane vesicles associated with ribosomes) in patients with advanced cancer.

Authors:  A Mittelman; R Urban; G Wong; T Ahmed; Z Arlin
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 2.  Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.

Authors:  Bruno Mendes Roatt; Rodrigo Dian de Oliveira Aguiar-Soares; Wendel Coura-Vital; Henrique Gama Ker; Nádia das Dores Moreira; Juliana Vitoriano-Souza; Rodolfo Cordeiro Giunchetti; Cláudia Martins Carneiro; Alexandre Barbosa Reis
Journal:  Front Immunol       Date:  2014-06-13       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.